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Statistics and Data 
• One third of the world is infected with 
TB. In 2013, there were around 1.5 
million TB-related deaths worldwide 
(Centers for Disease Control and 
Prevention [CDC], 2014). 
• The rate of TB in older adults is 
increasing. It approached 60,000 cases 
in 2012 (CDC, 2014). 
• TB is the leading killer of people 
infected with HIV (CDC, 2014). 
• In the U.S. TB is primarily a disease of 
foreign-born people. The TB case rate 
among Africans in the U.S. is 3 times 
higher than other foreign-born people 
and 27 times higher than U.S. born 
people (Bennett, Brodine, Waalen, 
Moser, & Rodwell, 2014).  
• Latently infected individuals produce 
most cases of active disease in low TB 
incidence countries, as opposed to 
high TB burden countries, where most 
cases of active disease come from 
active transmission (Ahmad, 2011). 
areas, are key to prevent active disease 
and control TB (Stagg et al, 2014). The 
screening for LTBI should be widely 
practiced in persons at high risk followed 
by treatment as a preventive measure 
against active TB (Lee, Meintjes, 
Kamarulzaman, & Leung, 2013).  In 
general, testing should only be offered 
when preventive treatment will be 
accepted, in the case of a positive result 
(Chee et al., 2013). In the U.S. the greatest 
incidence and prevalence of LTBI is among 
foreign-born populations (Morano et al, 
2014). It can be concluded that TB is a 
preventable and curable disease. 
Tuberculosis (TB) is a major health 
concern not only in the United States, but 
in the entire world. TB is an airborne 
communicable infection which has affected 
human beings from immemorial times, 
evidenced by TB being found in the skeletal 
remains of ancient mummies (Gough & 
Kaufman, 2011). There are many patho 
physiological events in TB that concern the 
entire body, especially the respiratory and 
immunological systems.  
According to Knechel, TB prevalence is 
rising due to the increased number of 
patients infected with HIV, bacterial 
resistance to medications, increased 
international travel and immigration from 
countries with high prevalence of TB, and 
the growing numbers of the homeless and 
drug abusers. The immune system declines 
with age. Therefore, the elderly are more 
susceptible to TB disease, (2009). Latent 
tuberculosis infection (LTBI) is a type of TB 
where some producing disease bacilli 
evade the immune system response, which 
causes their survival and persistence in a 
non-replicating state in the host.  
The importance of LTBI is that people 
who have this disease are not contagious, 
but they are at risk of developing an active 
infection which is symptomatic and 
contagious. About 90 % of people who 
become infected with TB develop a LTBI 
(Shi, Shi, & Xu, 2011).  
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The presence of an M. tb immune 
response in the absence of active TB is 
defined as LTBI (Chee, Sester, Zhang, & 
Lange, 2013).  The inability of otherwise an 
effective immune response to completely 
eliminate the pathogen is the hallmark of 
M. tb (Ahmad, 2011).  Although the 
mycobacterial granuloma is a host defense 
mechanism for walling off M. tuberculosis, 
the bacilli can also survive, protected from 
killing by immune cells, and persists in a 
latent form until a circumstance arises for 
reactivation and dissemination.  
In the U.S.  and other high income 
countries with a low incidence of TB, most 
new cases of TB arise from reactivation of 
LTBI. Therefore, screening and treatment 
especially for groups at high risk for 
reactivation, such as contacts of patients 
with pulmonary TB, immunocompromised 
persons, and migrants from high-incidence  
 
Conclusion 
and activate macrophages to kill 
intracellular bacilli.  Interleukin-17 is 
associated with a pro-inflammatory 
response. It has been suggested that this 
interleukin promotes polymorphonuclear 
leukocytes recruitment and organization 
around the foci of infection during early 
stages of granuloma formation (Guirado & 
Schlesinger, 2013). 
The most important single factor  for 
progression to active disease in adults is 
HIV infection. HIV causes depletion of CD4 
T cells and functional abnormalities of CD4 
and CD8 T cells which play a key role in 
providing protection against active TB 
(Ahmad, 2011). Likewise, alterations in the 
immune system that affect T cells function 
such as decreased cytokine production, 
cytotoxic activity, and T cell proliferation, 
occur during the aging process. Other 
diseases (e.g., diabetes mellitus), poor 
nutrition, and immune suppression are 
other factors that also impact the 
protective granulomatous response against 
M. tb during aging.  
    On one hand, the role of the 
granulomas is to localize and contain the 
bacilli while concentrating the immune 
response to a limited area. On the other 
hand, since M. tb has its own strategies to 
persist within the granuloma and to 
reactivate and scape during certain 
conditions, complete eradication does not 
occur. 80 % of the time reactivation occurs in 
the lungs, whereas in 20% of the cases TB 
reactivates at other tissues such as pleural 
space, lymph nodes, bone, and kidneys, due 
to the early dissemination process that occurs 
during primary infection (Guirado & 
Schlesinger, 2013). Some classic symptoms of 
active TB are cough of at least three weeks of 
duration, hemoptysis, weight loss, fever, and 
nocturnal diaphoresis (Hartman-Adams al., 
2014).  
Tuberculin skin test (TST) and interferon 
gamma release essay (IGRA) are the tests 
available to diagnose TB. The two step TST 
is internationally recognized and is an 
accurate assessment of LTBI status in 
immuno-competent adults even if they 
have received the Bacillus Calmette-Gerin 
(BCG) vaccine (Morano, Zelenev, Walton, 
Bruce, & Altice, 2014). One major problem 
of TST is that it is not possible to make a 
reliable distinction of individuals infected 
with M. tb from individuals sensitized to 
other mycobacteria, including BCG (Dagnew 
et al., 2012). IGRA results can be obtained 
after a single visit. Therefore, IGRA has 
processing requirements and higher cost.  
 According to Hartman-Adams et al. 
(2014) “neither the TST nor the IGRA can 
distinguish between latent and active disease” 
(p. 893). In a person without  overt signs of 
the disease a LTBI is indicated by the delayed-
type hyper sensitivity response to the TST 
(Ahmad, 2011).  
Screening 
 As family nurse practitioners, we 
emphasize in health promotion and disease 
prevention in our daily practice. We can 
impact the clinical faith of persons with 
LTBI. By identifying persons at high risk and 
educating them in the importance of 
screening and appropriate preventive 
treatment, their infection may never 
progress to active TB.  Educating the 
community and individuals on the signs 
and symptoms of the disease is important, 
so that they can seek medical attention 
and initiate measures to control the spread 
of the disease. As we educate patients, the 
possibility of their decision to be screened 
and adhere to treatment is higher. 
Knowing the community where we 
work is important. We can perform 
assessments that identify persons more 
vulnerable to be sick, screen for the 
disease, and monitor treatment. According 
to Shimamura et al, patients that believe 
the nurse had a positive and genuine 
regard for him or her as an individual, was 
a key factor for successful treatment 
completion. The involvement of patient’s 
family members to assist in treatment 
adherence offered positive outcomes. In 
addition, emphasizing the importance of 
treatment compliance to patients, so their 
family members and other citizens would 
be protected from contracting the disease, 
was a great encouragement for patients to 
complete the treatment (2013). 
Epidemiological Triad. Tuberculosis is 
produced by Mycobacterium tuberculosis 
(M.tb). Mycobacteria are small non-
sporing, rod-shaped, acid-fast Gram 
positive bacilli that are aerophilic, which 
explains their affinity for the lungs. M.tb  
enters the host via the respiratory tract. 
Although M. tb can affect any part of the 
body, pulmonary  TB accounts for almost 
60 % of the cases and is the only cause of 
transmission of infection (Gough & 
Kaufman, 2011).  
The hosts are humans infected with 
TB. Persons with pulmonary TB are the 
most important source of infection. 
Infectiousness of the source case, the 
closeness of contact, bacillary load 
inhaled, and immune status of the 
potential host are factors that determine 
the risk of infection. (Gough & Kaufman, 
2011; Ahmad, 2011).  
Poverty and overcrowding conditions 
make a favorable environment for TB 
transmission. Institutionalized and 
homeless  people,  and illicit drug and 
alcohol abusers are at risk for latent to 
active disease progression. Likewise, 
persons with weakened immune systems 
such as the elderly and  diabetics, as well 
as untreated or inadequately treated 
active TB infected patients have increased 
risk of disease progression (Hartman-
Adams, Clark, & Juckett, 2014; CDC, 2012). 
Pathogenesis and 
Immune Response 
Infection is initiated by inhalation of 
particles of 1-5 micrometers in diameter 
that contain M. tuberculosis. These 
particles are called droplet nuclei and are 
expectorated by patients who have active 
TB, especially when they cough. Inhaled 
droplet nuclei penetrate into the terminal 
alveoli where they are engulfed by 
macrophages and dendritic cells (Gough & 
Kaufman, 2011; Ahmad, 2011). 
Once the M. tb is internalized, intra 
cellular replication occurs. According to 
Russell and Ramakrishnan (as cited in 
Guirado & Schlesinger, 2013), granulomas 
are well organized lesions  that contain 
blood-derived infected and uninfected 
macrophages, foamy macrophages, 
epithelioid cells, Langerhans cells, B and T 
lymphocytes, and fibroblasts around the 
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foci of infected cells (p. 1).  Granuloma 
formation starts shortly after infection, 
when inhaled M. tb is ingested and 
transported across the alveolar epithelium 
into the lungs and adjacent lymph nodes. 
Then, dissemination occurs through 
lymphatics and blood stream. As 
dissemination takes place, there is 
production of pro and anti-inflammatory 
cytokines and chemokines. The immune 
response generated stimulates the 
phagocyte antimicrobial activities which 
lead to the recruitment of additional 
mononuclear leucocytes into the site of 
infection.   Granulomas contain the 
growing necrotic tissue and limit replication 
and spread of the bacteria (Guirado & 
Schlesinger, 2013).  
M. tb can persist for decades within the 
granuloma in a non-replicating state. This is 
known as LTBI. As a result of a subsequent 
defect in cell-mediated immunity, 5 % to 10 
% of these individuals will develop 
reactivation of TB many years after the 
infection and will have active tuberculosis. 
A balance of pro and anti-inflammatory 
immune responses is essential for 
controlling proliferation of bacteria within 
granulomas and the resolution of these 
granulomas over time. Dysregulation in the 
immune response leads to granuloma 
progression and disease (Guirado & 
Schlesinger, 2013).  
Caseum accumulation in the core of the 
granuloma promotes necrotic tissue 
formation and the breakdown of the 
granuloma center. When the granuloma 
center collapses, there is release of   
infectious bacilli to other tissue parts, 
where more lesions will be formed. 
Collapse of granulomas within the airways 
can lead to the transmission of bacteria to 
other individuals (Guirado & Schlesinger, 
2013). Tumoral Necrosis factor (TNF) 
produced by infected macrophages and T 
cells maintains sustained levels of 
chemokines and cellular recruitment and 
retention. This role is crucial in maintaining 
the granuloma structure during the early 
stages of granuloma formation. In the 
regional lymph nodes, the accumulation of 
antigen presenting cells leads to the 
development of the adaptive immune 
response against M. tb. CD4, CD8 T cells, 
and the natural killer cells produce 
interferon gamma which works in 
collaboration with TNF-alfa to recognize  
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